Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways
…, M Kachman, H Baum, CF Burant, SL Mottl, RT Cartaxo… - Cancer discovery, 2023 - AACR
The clinical, radiographic, and molecular analyses included in this study demonstrate the
efficacy of ONC201 in H3K27M-mutant DMG and support ONC201 as the first monotherapy to …
efficacy of ONC201 in H3K27M-mutant DMG and support ONC201 as the first monotherapy to …
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma
…, RS Tarapore, K Ravi, C Thomas, R Cartaxo… - Neuro …, 2022 - academic.oup.com
Background Diffuse Midline Glioma (DMG) with the H3K27M mutation is a lethal childhood
brain cancer, with patients rarely surviving 2 years from diagnosis. Methods We conducted a …
brain cancer, with patients rarely surviving 2 years from diagnosis. Methods We conducted a …
Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma
Z Miklja, VN Yadav, RT Cartaxo… - The Journal of …, 2020 - Am Soc Clin Investig
Pediatric and adult high-grade gliomas (HGGs) frequently harbor PDGFRA alterations. We
hypothesized that cotreatment with everolimus may improve the efficacy of dasatinib in …
hypothesized that cotreatment with everolimus may improve the efficacy of dasatinib in …
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway …
Diffuse midline gliomas (DMGs) harboring loss of H3K27me3 due to H3K27M/I mutations or
EZHIP overexpression comprise a World Health Organization (WHO) defined subtype of …
EZHIP overexpression comprise a World Health Organization (WHO) defined subtype of …
A road map for the treatment of pediatric diffuse midline glioma
Recent clinical trials for H3K27-altered diffuse midline gliomas (DMGs) have shown much
promise. We present a consensus roadmap and identify three major barriers: (1) refinement of …
promise. We present a consensus roadmap and identify three major barriers: (1) refinement of …
[HTML][HTML] Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine
…, CM Babila, S Lyons, S Ji, RT Cartaxo… - Frontiers in …, 2022 - frontiersin.org
Pediatric high-grade glioma (pHGG), including both diffuse midline glioma (DMG) and non-midline
tumors, continues to be one of the deadliest oncologic diagnoses (both henceforth …
tumors, continues to be one of the deadliest oncologic diagnoses (both henceforth …
[PDF][PDF] Metodologia de priorização para produção nacional dos medicamentos pertencentes à lista do sistema único de saúde
RJA Cartaxo - Rio de Janeiro: INPI, 2011 - gov.br
Atualmente um dos focos do governo brasileiro, juntamente com suas políticas, é conter o
déficit comercial do setor farmacêutico a partir do incentivo de vínculos entre produção e …
déficit comercial do setor farmacêutico a partir do incentivo de vínculos entre produção e …
Crosstalk between kinases, phosphatases and miRNAs in cancer
…, KJ Pelizzaro-Rocha, MB de Jesus, RT Cartaxo… - Biochimie, 2014 - Elsevier
Reversible phosphorylation of proteins, performed by kinases and phosphatases, is the
major post translational protein modification in eukaryotic cells. This intracellular event …
major post translational protein modification in eukaryotic cells. This intracellular event …
Produção de fármacos e medicamentos no Brasil: uma proposta de metodologia para priorização da lista estratégica no âmbito do SUS
R Cartaxo, AMS Antunes, JL Magalhães - 2014 - arca.fiocruz.br
Os desafios do novo século têm proporcionado aos países emergentes um desempenho
importante no protagonismo da economia global. A saúde pública é priorizada na agenda …
importante no protagonismo da economia global. A saúde pública é priorizada na agenda …
HGG-18. Clinical Efficacy of ONC201 in thalamic H3 K27M-mutant glioma
…, Y Umemura, J Schwartz, V Yadav, R Cartaxo… - Neuro …, 2020 - academic.oup.com
Pediatric high-grade gliomas (pHGG) are heterogeneous brain tumors for which new
specific diagnostic/prognostic biomarkers are needed. In this study, we aimed to identify new …
specific diagnostic/prognostic biomarkers are needed. In this study, we aimed to identify new …
